Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczyński, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 869-900
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
HPV Infections—Classification, Pathogenesis, and Potential New Therapies
Beata Mlynarczyk-Bonikowska, Lidia Rudnicka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7616-7616
Open Access | Times Cited: 13
Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management – a comprehensive review
Naina Kumar, Mishu Mangla
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access | Times Cited: 1
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12963-12963
Open Access | Times Cited: 20
The roles of Th cells in myocardial infarction
Jun Liu, Feila Liu, Tingting Liang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
An engineered Accum‐E7 protein‐based vaccine with dual anti‐cervical cancer activity
Jean‐Pierre Bikorimana, Jamilah Abusarah, Marina Gonçalves, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1102-1113
Open Access | Times Cited: 6
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 13
Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction
Kexin Zhang, Qiliang Yin, Y.F. Ma, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
The role of nanotechnologies in diagnostics and treatment of female reproductive system cancer
Z. R. Faizullina, A. A. Zhilenko, Almaz Kh. Islamgulov, et al.
Obstetrics Gynecology and Reproduction (2025)
Open Access
HPV vaccines – a game changer for preventing HPV-related cancers
John Dickson Calvin Devadasan, Karthick Nithyanandhan, Gnanadurai John Fletcher, et al.
Indian Journal of Medical Microbiology (2025), pp. 100847-100847
Open Access
Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection
Feng Xu, Ye Yuan, Ying Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114117-114117
Open Access | Times Cited: 19
Liposomal Formulations of a Polyleucine–Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer
Farrhana Ziana Firdaus, Stacey Bartlett, Waleed M. Hussein, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 602-602
Open Access | Times Cited: 12
A Factorial Design-optimized Microfluidic LNP Vaccine Elicits Potent Magnesium-Adjuvating Cancer Immunotherapy
Y. G. Xie, Jiaxin Guo, Jialin Hu, et al.
Materials Today Bio (2025), pp. 101703-101703
Open Access
The Role and Development of Peptide Vaccines in Cervical Cancer Treatment
Minhui Wang, Yanyu Gong, Wenyan Kang, et al.
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 3
Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses
Qiliang Yin, Ying Wang, Yipeng Xiang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 13
Vaginal Ovule Loaded with Bismuth Lipophilic Nanoparticles and Cetylpyridinium Chloride Inhibits Human Cervical Carcinoma and Candida albicans Growth
Claudio Cabral‐Romero, Rene Hernández‐Delgadillo, Jesús Alejandro Torres-Betancourt, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 206-206
Open Access | Times Cited: 2
Nanotechnology based vaccines: Cervical cancer management and perspectives
Ridhima Jasrotia, Daljeet Singh Dhanjal, Sonali Bhardwaj, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 71, pp. 103351-103351
Closed Access | Times Cited: 12
Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy
Dandan Wang, Wenxing Gu, Weiliang Chen, et al.
Coordination Chemistry Reviews (2022) Vol. 472, pp. 214788-214788
Closed Access | Times Cited: 12
Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis
Xuefang Mei, Rui Zhang, Dongxian Li, et al.
Journal of Obstetrics and Gynaecology (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Exploring the Molecular Pathogenesis, Pathogen Association, and Therapeutic Strategies against HPV Infection
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Pathogens (2022) Vol. 12, Iss. 1, pp. 25-25
Open Access | Times Cited: 9
A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach
Sari Eka Pratiwi, Ysrafil Ysrafil, Mardhia Mardhia, et al.
Bioimpacts (2024) Vol. 14, pp. 27846-27846
Open Access | Times Cited: 1
Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods
Alexandru Tîrziu, Speranța Avram, Leonard Mada, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1798-1798
Open Access | Times Cited: 4
A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™
Patrick L. Iversen, Nicholas Kipshidze, Nodar Kipshidze, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Human Papillomavirus Type 16 Based L1, L2, E6, and E7 Peptide Microspheres Induce Encapsulated Peptide Mixture Specific Cytotoxic T Lymphocytes and Tumor Regression in a Murine Model of Cervical Cancer
M Khan, Kashif Ali, M. Moshahid A. Rizvi
Cancer Screening and Prevention (2024) Vol. 3, Iss. 2, pp. 85-90
Open Access | Times Cited: 1
Polydopamine encapsulated new indocyanine green theranostic nanoparticles for enhanced photothermal therapy in cervical cancer HeLa cells
Huimin Fan, Ting Yan, Shuang Chen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top